Patent · US Active

Compounds and methods for selective proteolysis of glucocorticoid receptors

US11998606B2 · kind B2 · utility

0Cited by
0References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2019
Grant dateJun 4, 2024
Priority date
Expiry dateAug 27, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J43/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to steroidal glucocorticoid receptor (GR) ligands and related compositions that degrade the GR and/or modulate its activity that may be utilized as pharmaceuticals for the treatment of diseases including cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.